Connecticut Cannabis Sales
Dec, 2025
Overview
Connecticut’s cannabis market closed December 2025 with sales of $26.1 million, capping a year of steady, if modest, growth. Over the past 12 months, monthly sales have generally hovered between $22–26 million, with a notable uptick of 8.9% month-over-month in December. Year-over-year, the market grew by 2.5%, signaling resilience despite some volatility earlier in the year. Pricing remains a defining feature: the average item price in December 2025 was $29.88, making Connecticut one of the highest-priced cannabis markets in the country. This premium pricing is likely influenced by limited competition and a tightly regulated supply chain.
While Connecticut’s growth rate is outpaced by some newer or rapidly expanding markets, its pricing power stands out. Consumers here are paying nearly double the average item price seen in mature markets like Michigan or Oregon. This dynamic suggests a market still in its early stages, with room for both price normalization and volume expansion as more operators enter and consumer familiarity grows.
Dec, 2025
Sales
Year Over Year
Growth
Market Comparison
Connecticut’s market size is modest compared to leading states, but its average item price of $29.88 is among the highest nationally. For context, California’s average item price is $18.41, Michigan’s is just $8.45, and even neighboring Massachusetts sits at $17.46. In terms of total sales, Connecticut’s $26.1 million in December 2025 is dwarfed by California ($348.4 million), Michigan ($262.4 million), and Massachusetts ($141.9 million). However, Connecticut’s 2.5% year-over-year growth outpaces mature markets like Colorado (-3.5%) and Oregon (-3.8%), though it lags behind fast-growing states like New York (+37.8%) and Ohio (+18.4%).
Connecticut Weed Prices
Category Performance
Among all categories, Pre-Rolls are showing a particularly dynamic trend, diverging from the overall market’s modest growth. In December 2025, Pre-Roll sales reached $3.8 million, up 39.0% year-over-year and 6.6% month-over-month. Unit sales more than doubled year-over-year (+105.7%), indicating surging consumer interest and increased accessibility. Notably, average item prices for Pre-Rolls have dropped sharply over the past year, from $23.23 in December 2024 to $15.69 in December 2025, making them more attractive to price-sensitive shoppers.
Within Pre-Rolls, the Hybrid - Single Strain segment dominates, accounting for over $2 million in sales and 151,946 units in December. The Connoisseur/Infused segment is also gaining traction, with sales of $944K and robust triple-digit growth. On the brand front, CTPharma leads the pack, followed by Theraplant and Curaleaf. These brands command significant market share, but lower-priced entrants like Awssom and Springtime are gaining ground as price competition intensifies.





